TY - JOUR
T1 - Type III interferons induce pyroptosis in gut epithelial cells and impair mucosal repair
AU - Jena, Kautilya K.
AU - Mambu, Julien
AU - Boehmer, Daniel
AU - Sposito, Benedetta
AU - Millet, Virginie
AU - de Sousa Casal, Joshua
AU - Muendlein, Hayley I.
AU - Spreafico, Roberto
AU - Fenouil, Romain
AU - Spinelli, Lionel
AU - Wurbel, Sarah
AU - Riquier, Chloé
AU - Galland, Franck
AU - Naquet, Philippe
AU - Chasson, Lionel
AU - Elkins, Megan
AU - Mitsialis, Vanessa
AU - Ketelut-Carneiro, Natália
AU - Bugda Gwilt, Katlynn
AU - Thiagarajah, Jay R.
AU - Ruan, Hai Bin
AU - Lin, Zhaoyu
AU - Lien, Egil
AU - Shao, Feng
AU - Chou, Janet
AU - Poltorak, Alexander
AU - Ordovas-Montanes, Jose
AU - Fitzgerald, Katherine A.
AU - Snapper, Scott B.
AU - Broggi, Achille
AU - Zanoni, Ivan
N1 - Publisher Copyright:
© 2024 Elsevier Inc.
PY - 2024/12/26
Y1 - 2024/12/26
N2 - Tissue damage and repair are hallmarks of inflammation. Despite a wealth of information on the mechanisms that govern tissue damage, mechanistic insight into how inflammation affects repair is lacking. Here, we investigated how interferons influence tissue repair after damage to the intestinal mucosa. We found that type III, not type I or type II, interferons delay epithelial cell regeneration by inducing the upregulation of Z-DNA-binding protein 1 (ZBP1). Z-nucleic acids formed following intestinal damage are sensed by ZBP1, leading to caspase-8 activation and the cleavage of gasdermin C (GSDMC). Cleaved GSDMC drives epithelial cell death by pyroptosis and delays repair of the large or small intestine after colitis or irradiation, respectively. The type III interferon/ZBP1/caspase-8/GSDMC axis is also active in patients with inflammatory bowel disease (IBD). Our findings highlight the capacity of type III interferons to delay gut repair, which has implications for IBD patients or individuals exposed to radiation therapies.
AB - Tissue damage and repair are hallmarks of inflammation. Despite a wealth of information on the mechanisms that govern tissue damage, mechanistic insight into how inflammation affects repair is lacking. Here, we investigated how interferons influence tissue repair after damage to the intestinal mucosa. We found that type III, not type I or type II, interferons delay epithelial cell regeneration by inducing the upregulation of Z-DNA-binding protein 1 (ZBP1). Z-nucleic acids formed following intestinal damage are sensed by ZBP1, leading to caspase-8 activation and the cleavage of gasdermin C (GSDMC). Cleaved GSDMC drives epithelial cell death by pyroptosis and delays repair of the large or small intestine after colitis or irradiation, respectively. The type III interferon/ZBP1/caspase-8/GSDMC axis is also active in patients with inflammatory bowel disease (IBD). Our findings highlight the capacity of type III interferons to delay gut repair, which has implications for IBD patients or individuals exposed to radiation therapies.
KW - Z-nucleic acid
KW - colitis
KW - damage
KW - gasdermin
KW - inflammation
KW - inflammatory bowel disease
KW - interferons
KW - intestinal epithelial cell
KW - intestinal stem cell
KW - irradiation
KW - pattern recognition receptors
KW - pyroptosis
KW - repair
UR - http://www.scopus.com/inward/record.url?scp=85210103835&partnerID=8YFLogxK
U2 - 10.1016/j.cell.2024.10.010
DO - 10.1016/j.cell.2024.10.010
M3 - Article
C2 - 39500322
AN - SCOPUS:85210103835
SN - 0092-8674
VL - 187
SP - 7533-7550.e23
JO - Cell
JF - Cell
IS - 26
ER -